Skip to main content
Xellia

We are Xellia

Built for continuity. Focused on what matters.

In anti-infectives, what matters is not just what you make — but whether it’s there when it’s needed.

As supply chains become more complex and critical APIs disappear from Western production, continuity can no longer be taken for granted. It has to be built, maintained, and protected over time.

That is where we focus.

Xellia's leadership

Meet our experienced executive team, leading Xellia into the future.

Michael Kocher

26_0225_Xellia_Excutives_Michael_Contact.jpg

Chief Executive Officer

Michael joined Xellia as Chief Executive Officer in October 2023, bringing extensive global experience from the anti-infective industry.

Michael Kocher

Gaël Bernard

26_0225_Xellia_Excutives_Gael_Contact.jpg

Chief Commercial Officer

Gaël Bernard has spent nearly three decades in the pharmaceutical industry, building and leading businesses across global markets.

Gaël Bernard

Florian Falch

26_0225_Xellia_Excutives_Florian_Contact.jpg

Chief People & Culture Officer

Florian Falch joined Xellia in September 2023 and brings extensive experience in strategy, transformation, and M&A from the global pharmaceutical industry.

Florian Falch

Vicente Oller

26_0225_Xellia_Excutives_Vincente_Contact.jpg

Chief Financial Officer

Vicente joined Xellia Pharmaceuticals in September 2024 prior to that, he was the CFO of the Global B2B business at Sandoz and served as the Country CFO for Sandoz Austria.

Vicente Oller

Alexander Sproedt

26_0225_Xellia_Excutives_Alex_Contact.jpg

Chief Operations Officer

Alex joined Xellia in November 2024 and serves as Chief Operations Officer, bringing more than a decade of experience across the Life Sciences industry.

Alexander Sproedt